Hudson Bay Capital Management »

Acumen Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 564k 3.84
2023-09-30 $2.2M 525k 4.15
2023-06-30 $1.9M 395k 4.81
2023-03-31 $1.4M 357k 4.06
2022-12-31 $1.3M 240k 5.40

More positions owned by Hudson Bay Capital Management

Amazon Call Option (AMZN)
Microsoft Corporation Put Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Meta Platforms Cl A Put Option (META)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Alphabet Cap Stk Cl C Put Option (GOOG)
Apple Put Option (AAPL)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
NVIDIA Corporation Put Option (NVDA)
salesforce Put Option (CRM)
Select Sector Spdr Tr Financial (XLF)
Adobe Systems Incorporated Put Option (ADBE)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Franklin Resources
Laurion Capital Management
Vanguard Group
Millennium Management
Alyeska Investment Group
Jane Street
Hudson Bay Capital Management
Schonfeld Strategic Advisors
Pathstone Holdings
Ikarian Capital
Tang Capital Management
Two Sigma Investments
Citigroup
Man Group

View all funds holding Acumen Pharmaceuticals